Sonoma Pharmaceuticals, Inc.
About Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $14.3M
- Net income
- -$3.5M
- Total assets
- $13.7M
- Market cap
- $4.0M
Source: SEC EDGAR · updated Jun 7, 2026
- Market cap
- $4.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 25, 2007
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review Sonoma Pharmaceuticals, Inc..
